Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Clinical outcomes of patients with heart failure and preserved ejection fraction in Chinese

View through CrossRef
Background Although heart failure is recognised as a major health problem, little is known about heart failure with preserved ejection fraction (HFPEF) in the Chinese population. Therefore, we observed the clinical characteristics and outcomes of patients with HFPEF in China. Methods All patients admitted with heart failure were divided into the HFPEF (EF 3 50%) and reduced ejection fraction (HFREF, EF<50%) groups. EF was determined by echocardiography, and clinical data were collected from a secure web-based system. Results Out of the 534 patients with heart failure, 269 (50.4%) had HFPEF. Compared to patients with HFREF, patients with HFPEF were older, were more likely to be female and had a higher prevalence of hypertension. The in-hospital mortality of patients with HFPEF (3.7%) was comparable to that of patients with HFREF (4.5%). After a mean follow-up period of 321 days, the survival of patients with HFPEF (12.7%) was significantly better than that of patients with HFREF (23.3%, p=0.02). Cox proportional hazard regression identified serum creatinine levels (HR 1.006, 95% CI 1.001 to 1.009, p=0.009) and hypertension (HR 2.104, 95% CI 1.016 to 4.359, p=0.045) as predictors of survival for patients with HFPEF. Conclusions HFPEF is common in China. Although the in-hospital mortality of patients with HFPEF was comparable to that of patients with HFREF, the survival of patients with HFPEF was significantly better than that of patients with HFREF during a follow-up period lasting more than half a year after discharge.
Title: Clinical outcomes of patients with heart failure and preserved ejection fraction in Chinese
Description:
Background Although heart failure is recognised as a major health problem, little is known about heart failure with preserved ejection fraction (HFPEF) in the Chinese population.
Therefore, we observed the clinical characteristics and outcomes of patients with HFPEF in China.
Methods All patients admitted with heart failure were divided into the HFPEF (EF 3 50%) and reduced ejection fraction (HFREF, EF<50%) groups.
EF was determined by echocardiography, and clinical data were collected from a secure web-based system.
Results Out of the 534 patients with heart failure, 269 (50.
4%) had HFPEF.
Compared to patients with HFREF, patients with HFPEF were older, were more likely to be female and had a higher prevalence of hypertension.
The in-hospital mortality of patients with HFPEF (3.
7%) was comparable to that of patients with HFREF (4.
5%).
After a mean follow-up period of 321 days, the survival of patients with HFPEF (12.
7%) was significantly better than that of patients with HFREF (23.
3%, p=0.
02).
Cox proportional hazard regression identified serum creatinine levels (HR 1.
006, 95% CI 1.
001 to 1.
009, p=0.
009) and hypertension (HR 2.
104, 95% CI 1.
016 to 4.
359, p=0.
045) as predictors of survival for patients with HFPEF.
Conclusions HFPEF is common in China.
Although the in-hospital mortality of patients with HFPEF was comparable to that of patients with HFREF, the survival of patients with HFPEF was significantly better than that of patients with HFREF during a follow-up period lasting more than half a year after discharge.

Related Results

Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Comorbidities and sex differences in chronic heart failure of ischemic etiology
Comorbidities and sex differences in chronic heart failure of ischemic etiology
Abstract Background: Comorbidities and sex differences play a major role in chronic heart failure (CHF). However, it is unknown whether the prevalence of comorbidities diff...
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Heart failure with reduced ejection fraction (HFrEF) remains a major clinical challenge worldwide and is a pressing public health issue in Pakistan. Patients here often present at ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Heart Failure With Preserved &#x2028;Ejection Fraction
Heart Failure With Preserved &#x2028;Ejection Fraction
Abstract Heart failure affects nearly 6 million Americans and represents the leading cause of hospitalization among patients aged 65 years and older. Of the total he...
Left Ventricular Function in Hospitalized Geriatric Patients
Left Ventricular Function in Hospitalized Geriatric Patients
ABSTRACT: Left ventricular ejection fraction was measured by gated wall motion in 62 patients, 75 years old or older, admitted to a Geriatric Acute Assessment War...
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Abstract Background Women with heart disease undergoing pregnancy is on the increase, along with an increasing cardiac contribut...

Back to Top